Breast Cancer Clinical Trials in Miami, FL

Breast Cancer Clinical Trials in Miami, FL

View the best 10 breast cancer medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Breast Cancer clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for breast cancer in Miami, Florida

Image of University of Florida Health Science Center - Gainesville in Gainesville, United States.

Copanlisib Hydrochloride +1 More

PI3K Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing the side effects and best dose of copanlisib given with eribulin for treating patients with advanced stage triple negative breast cancer.
Image of Memorial Sloan Kettering Basking Ridge (All Protocol Activities) in Basking Ridge, United States.

Eribulin +1 More

Chemotherapy

Recruiting0 awardsPhase 2
This trial is testing whether adding SDX-7320 to standard chemotherapy eribulin helps people with TNBC and metabolic dysfunction, and whether it is safe.
Image of University of Miami in Miami, United States.

Stereotactic Ablative Breast Radiotherapy

Radiation Therapy

Recruiting1 award10 criteria
This trial is testing a new, shorter radiation therapy regimen for breast cancer patients.
Image of Kaiser Permanente - Oakland in Oakland, United States.

Letrozole +2 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial will compare two treatments for breast cancer: giredestrant with palbociclib, and letrozole with palbociclib. The trial will measure how well the treatments work and how safe they are.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Decision Aid

Recruiting1 award22 criteria
This trial is testing web-based tools to help patients with early stage breast cancer make decisions about treatment. The goal is to learn how best to implement these tools in clinical practice.
Image of Ironwood Cancer & Research Centers in Chandler, United States.

Abemaciclib +2 More

Cyclin-Dependent Kinase Inhibitor

Recruiting3 awardsPhase 3
This trial will compare how well two treatments work in postmenopausal women with breast cancer. One treatment group will receive a nonsteroidal aromatase inhibitor plus abemaciclib. The other treatment group will receive a placebo plus abemaciclib.
Image of CBCC Global Research Inc., at Comprehensive Blood and Cancer Center in Bakersfield, United States.

Giredestrant +1 More

Selective Estrogen Receptor Degrader (SERD)

Recruiting2 awardsPhase 3
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Fludeoxyglucose F-18

Recruiting1 awardPhase 2
This trial studies how well certain scans work in assessing the response of patients with breast cancer that has spread to the bones. The scans use a special substance to highlight active cancer areas on detailed body images, helping doctors see if the treatment is working. These scans have been used successfully for various stages and evaluations of breast cancer.
Image of University of California at Davis in Davis, United States.

ONC-392 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Image of St. Bernards Medical Center in Jonesboro, United States.

Imlunestrant

Selective Estrogen Receptor Downregulator (SERD)

Recruiting2 awardsPhase 3
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.